P2Y2 nucleotide receptors enhance α-secretase-dependent amyloid precursor protein processing

Jean M. Camden, Ann M. Schrader, Ryan E. Camden, Fernando A. González, Laurie Erb, Cheikh Seye, Gary A. Weisman

Research output: Contribution to journalArticle

97 Citations (Scopus)

Abstract

The amyloid precursor protein (APP) is proteolytically processed by β- and γ-secretases to release amyloid β, the main component in senile plaques found in the brains of patients with Alzheimer disease. Alternatively, APP can be cleaved within the amyloid β domain by α-secretase releasing the non-amyloidogenic product sAPPα, which has been shown to have neuroprotective properties. Several G protein-coupled receptors are known to activate α-secretase-dependent processing of APP; however, the role of G protein-coupled nucleotide receptors in APP processing has not been investigated. Here it is demonstrated that activation of the G protein-coupled P2Y2 receptor (P2Y2R) subtype expressed in human 1321N1 astrocytoma cells enhanced the release of sAPPα in a time- and dose-dependent manner. P2Y2R-mediated sAPPα release was dependent on extracellular calcium but was not affected by 1,2-bis(2- aminophenosy)ethane-N,N,N,-trimethylammonium salt, an intracellular calcium chelator, indicating that P2Y2R-stimulated intracellular calcium mobilization was not involved. Inhibition of protein kinase C (PKC) with GF109203 or by PKC down-regulation with phorbol ester pre-treatment had no effect on UTP-stimulated sAPPα release, indicating a PKC-independent mechanism. U0126, an inhibitor of the mitogen-activated protein kinase pathway, partially inhibited sAPPα release by UTP, whereas inhibitors of Src-dependent epidermal growth factor receptor transactivation by P2Y 2Rs had no effect. The metalloprotease inhibitors phenanthroline and TAPI-2 and the furin inhibitor decanoyl-Arg-Val-Lys-Arg-chloromethylketone also diminished UTP-induced sAPPα release. Furthermore, small interfering RNA silencing of an endogenous adamalysin, ADAM10 or ADAM17/TACE, partially suppressed P2Y2R-activated sAPPα release, whereas treatment of cells with both ADAM10 and ADAM17/TACE small interfering RNAs completely abolished UTP-activated sAPPα release. These results may contribute to an understanding of the non-amyloidogenic processing of APP.

Original languageEnglish (US)
Pages (from-to)18696-18702
Number of pages7
JournalJournal of Biological Chemistry
Volume280
Issue number19
DOIs
StatePublished - May 13 2005
Externally publishedYes

Fingerprint

Purinergic P2Y2 Receptors
Amyloid Precursor Protein Secretases
Amyloid beta-Protein Precursor
Uridine Triphosphate
Nucleotides
G-Protein-Coupled Receptors
Protein Kinase C
Processing
GTP-Binding Proteins
Amyloid
Small Interfering RNA
Furin
Calcium
Ethane
Phenanthrolines
Astrocytoma
Amyloid Plaques
Metalloproteases
Phorbol Esters
RNA Interference

ASJC Scopus subject areas

  • Biochemistry

Cite this

Camden, J. M., Schrader, A. M., Camden, R. E., González, F. A., Erb, L., Seye, C., & Weisman, G. A. (2005). P2Y2 nucleotide receptors enhance α-secretase-dependent amyloid precursor protein processing. Journal of Biological Chemistry, 280(19), 18696-18702. https://doi.org/10.1074/jbc.M500219200

P2Y2 nucleotide receptors enhance α-secretase-dependent amyloid precursor protein processing. / Camden, Jean M.; Schrader, Ann M.; Camden, Ryan E.; González, Fernando A.; Erb, Laurie; Seye, Cheikh; Weisman, Gary A.

In: Journal of Biological Chemistry, Vol. 280, No. 19, 13.05.2005, p. 18696-18702.

Research output: Contribution to journalArticle

Camden, JM, Schrader, AM, Camden, RE, González, FA, Erb, L, Seye, C & Weisman, GA 2005, 'P2Y2 nucleotide receptors enhance α-secretase-dependent amyloid precursor protein processing', Journal of Biological Chemistry, vol. 280, no. 19, pp. 18696-18702. https://doi.org/10.1074/jbc.M500219200
Camden, Jean M. ; Schrader, Ann M. ; Camden, Ryan E. ; González, Fernando A. ; Erb, Laurie ; Seye, Cheikh ; Weisman, Gary A. / P2Y2 nucleotide receptors enhance α-secretase-dependent amyloid precursor protein processing. In: Journal of Biological Chemistry. 2005 ; Vol. 280, No. 19. pp. 18696-18702.
@article{e8f051e78f034db887805690891b1da4,
title = "P2Y2 nucleotide receptors enhance α-secretase-dependent amyloid precursor protein processing",
abstract = "The amyloid precursor protein (APP) is proteolytically processed by β- and γ-secretases to release amyloid β, the main component in senile plaques found in the brains of patients with Alzheimer disease. Alternatively, APP can be cleaved within the amyloid β domain by α-secretase releasing the non-amyloidogenic product sAPPα, which has been shown to have neuroprotective properties. Several G protein-coupled receptors are known to activate α-secretase-dependent processing of APP; however, the role of G protein-coupled nucleotide receptors in APP processing has not been investigated. Here it is demonstrated that activation of the G protein-coupled P2Y2 receptor (P2Y2R) subtype expressed in human 1321N1 astrocytoma cells enhanced the release of sAPPα in a time- and dose-dependent manner. P2Y2R-mediated sAPPα release was dependent on extracellular calcium but was not affected by 1,2-bis(2- aminophenosy)ethane-N,N,N,-trimethylammonium salt, an intracellular calcium chelator, indicating that P2Y2R-stimulated intracellular calcium mobilization was not involved. Inhibition of protein kinase C (PKC) with GF109203 or by PKC down-regulation with phorbol ester pre-treatment had no effect on UTP-stimulated sAPPα release, indicating a PKC-independent mechanism. U0126, an inhibitor of the mitogen-activated protein kinase pathway, partially inhibited sAPPα release by UTP, whereas inhibitors of Src-dependent epidermal growth factor receptor transactivation by P2Y 2Rs had no effect. The metalloprotease inhibitors phenanthroline and TAPI-2 and the furin inhibitor decanoyl-Arg-Val-Lys-Arg-chloromethylketone also diminished UTP-induced sAPPα release. Furthermore, small interfering RNA silencing of an endogenous adamalysin, ADAM10 or ADAM17/TACE, partially suppressed P2Y2R-activated sAPPα release, whereas treatment of cells with both ADAM10 and ADAM17/TACE small interfering RNAs completely abolished UTP-activated sAPPα release. These results may contribute to an understanding of the non-amyloidogenic processing of APP.",
author = "Camden, {Jean M.} and Schrader, {Ann M.} and Camden, {Ryan E.} and Gonz{\'a}lez, {Fernando A.} and Laurie Erb and Cheikh Seye and Weisman, {Gary A.}",
year = "2005",
month = "5",
day = "13",
doi = "10.1074/jbc.M500219200",
language = "English (US)",
volume = "280",
pages = "18696--18702",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "19",

}

TY - JOUR

T1 - P2Y2 nucleotide receptors enhance α-secretase-dependent amyloid precursor protein processing

AU - Camden, Jean M.

AU - Schrader, Ann M.

AU - Camden, Ryan E.

AU - González, Fernando A.

AU - Erb, Laurie

AU - Seye, Cheikh

AU - Weisman, Gary A.

PY - 2005/5/13

Y1 - 2005/5/13

N2 - The amyloid precursor protein (APP) is proteolytically processed by β- and γ-secretases to release amyloid β, the main component in senile plaques found in the brains of patients with Alzheimer disease. Alternatively, APP can be cleaved within the amyloid β domain by α-secretase releasing the non-amyloidogenic product sAPPα, which has been shown to have neuroprotective properties. Several G protein-coupled receptors are known to activate α-secretase-dependent processing of APP; however, the role of G protein-coupled nucleotide receptors in APP processing has not been investigated. Here it is demonstrated that activation of the G protein-coupled P2Y2 receptor (P2Y2R) subtype expressed in human 1321N1 astrocytoma cells enhanced the release of sAPPα in a time- and dose-dependent manner. P2Y2R-mediated sAPPα release was dependent on extracellular calcium but was not affected by 1,2-bis(2- aminophenosy)ethane-N,N,N,-trimethylammonium salt, an intracellular calcium chelator, indicating that P2Y2R-stimulated intracellular calcium mobilization was not involved. Inhibition of protein kinase C (PKC) with GF109203 or by PKC down-regulation with phorbol ester pre-treatment had no effect on UTP-stimulated sAPPα release, indicating a PKC-independent mechanism. U0126, an inhibitor of the mitogen-activated protein kinase pathway, partially inhibited sAPPα release by UTP, whereas inhibitors of Src-dependent epidermal growth factor receptor transactivation by P2Y 2Rs had no effect. The metalloprotease inhibitors phenanthroline and TAPI-2 and the furin inhibitor decanoyl-Arg-Val-Lys-Arg-chloromethylketone also diminished UTP-induced sAPPα release. Furthermore, small interfering RNA silencing of an endogenous adamalysin, ADAM10 or ADAM17/TACE, partially suppressed P2Y2R-activated sAPPα release, whereas treatment of cells with both ADAM10 and ADAM17/TACE small interfering RNAs completely abolished UTP-activated sAPPα release. These results may contribute to an understanding of the non-amyloidogenic processing of APP.

AB - The amyloid precursor protein (APP) is proteolytically processed by β- and γ-secretases to release amyloid β, the main component in senile plaques found in the brains of patients with Alzheimer disease. Alternatively, APP can be cleaved within the amyloid β domain by α-secretase releasing the non-amyloidogenic product sAPPα, which has been shown to have neuroprotective properties. Several G protein-coupled receptors are known to activate α-secretase-dependent processing of APP; however, the role of G protein-coupled nucleotide receptors in APP processing has not been investigated. Here it is demonstrated that activation of the G protein-coupled P2Y2 receptor (P2Y2R) subtype expressed in human 1321N1 astrocytoma cells enhanced the release of sAPPα in a time- and dose-dependent manner. P2Y2R-mediated sAPPα release was dependent on extracellular calcium but was not affected by 1,2-bis(2- aminophenosy)ethane-N,N,N,-trimethylammonium salt, an intracellular calcium chelator, indicating that P2Y2R-stimulated intracellular calcium mobilization was not involved. Inhibition of protein kinase C (PKC) with GF109203 or by PKC down-regulation with phorbol ester pre-treatment had no effect on UTP-stimulated sAPPα release, indicating a PKC-independent mechanism. U0126, an inhibitor of the mitogen-activated protein kinase pathway, partially inhibited sAPPα release by UTP, whereas inhibitors of Src-dependent epidermal growth factor receptor transactivation by P2Y 2Rs had no effect. The metalloprotease inhibitors phenanthroline and TAPI-2 and the furin inhibitor decanoyl-Arg-Val-Lys-Arg-chloromethylketone also diminished UTP-induced sAPPα release. Furthermore, small interfering RNA silencing of an endogenous adamalysin, ADAM10 or ADAM17/TACE, partially suppressed P2Y2R-activated sAPPα release, whereas treatment of cells with both ADAM10 and ADAM17/TACE small interfering RNAs completely abolished UTP-activated sAPPα release. These results may contribute to an understanding of the non-amyloidogenic processing of APP.

UR - http://www.scopus.com/inward/record.url?scp=21444459918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21444459918&partnerID=8YFLogxK

U2 - 10.1074/jbc.M500219200

DO - 10.1074/jbc.M500219200

M3 - Article

VL - 280

SP - 18696

EP - 18702

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 19

ER -